Updates are available Correction dated 2020-12-10
Click to view Correction: https://doi.org/10.1038/s42255-020-00328-w
-
Authors
Covarrubias, Anthony J. https://orcid.org/0000-0002-7884-652X
Kale, Abhijit https://orcid.org/0000-0002-1105-6953
Perrone, Rosalba https://orcid.org/0000-0001-8894-4548
Lopez-Dominguez, Jose Alberto https://orcid.org/0000-0001-8733-3294
Pisco, Angela Oliveira
Kasler, Herbert G.
Schmidt, Mark S. https://orcid.org/0000-0003-4593-4096
Heckenbach, Indra
Kwok, Ryan https://orcid.org/0000-0002-1850-6611
Wiley, Christopher D.
Wong, Hoi-Shan https://orcid.org/0000-0002-9846-7842
Gibbs, Eddy
Iyer, Shankar S.
Basisty, Nathan
Wu, Qiuxia
Kim, Ik-Jung
Silva, Elena
Vitangcol, Kaitlyn
Shin, Kyong-Oh
Lee, Yong-Moon https://orcid.org/0000-0002-1551-9206
Riley, Rebeccah
Ben-Sahra, Issam https://orcid.org/0000-0001-9333-4162
Ott, Melanie
Schilling, Birgit https://orcid.org/0000-0001-9907-2749
Scheibye-Knudsen, Morten
Ishihara, Katsuhiko https://orcid.org/0000-0002-2826-5188
Quake, Stephen R.
Newman, John https://orcid.org/0000-0002-8455-0100
Brenner, Charles https://orcid.org/0000-0002-4955-3226
Campisi, Judith
Verdin, Eric https://orcid.org/0000-0003-3703-3183
- License Information
-
More Information
Article History
Received: 31 July 2019
Accepted: 25 September 2020
First Online: 16 November 2020
Change Date: 10 December 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: All authors have reviewed and approved the manuscript. C.B. is the inventor of intellectual property on the nutritional and therapeutic uses of NR, serves as chief scientific advisor of and holds stock in ChromaDex. E.V. is a scientific cofounder of NAPA Therapeutics. A.J.C., R.P., Q.W., E.S. and K.V. received partial salary support from NAPA Therapeutics. J.C. is a scientific cofounder of Unity Biotechnology. The other authors declare no competing interests.
